Panel discussion: Potential resistance targets, recent study results and new trial concepts

Date 09 May 2015
Event IMPAKT 2015
Session Triple negative breast cancer: First results from tackling the diversity
Topics Anti-Cancer Agents & Biologic Therapy
Breast Cancer
Pathology/Molecular Biology
Translational Research
Presenter Gunter von Minckwitz
Authors P. Schmid1, F. André2, I. Krop3, J. Reis-Filho4, F. Symmans5, A. Tutt6, N. Turner7, G. von Minckwitz8
  • 1Medical Oncology, Barts Cancer Institute-Queen Mary University of London, EC1M 6BQ - London/UK
  • 2Breast Cancer Unit, Institut Gustave Roussy, Villejuif/FR
  • 3Dana-Farber Cancer Institute, MA, 02215 - Boston/US
  • 4Department Of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 - New York, NY/US
  • 5Cancer Center, University of Texas MD Anderson, TX 77030 - Houston/US
  • 6Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London/UK
  • 7The Institute Of Cancer Research, Division of Breast Cancer Research, SW3 6JB - London/UK
  • 8Managing Director, GBG Forschungs GmbH, 63263 - Neu-Isenburg/DE